http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2412550-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdf849c32d7e0f41780c1a6b776dc1e3 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 1978-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1979-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | FR-2412550-A1 |
titleOfInvention | 3-CARBOXYRIFAMYCINS S AND SV DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR APPLICATION AS MEDICINAL PRODUCTS |
abstract | THESE DERIVATIVES ARE REPRESENTED BY THE TWO FOLLOWING FORMULAS. THEY ARE PREPARED BY OXIDATION OF CYANHYDRIN FROM 3-FORMYLRIFAMYCIN S TO 3- (CYANOCARBONYL) -RIFAMYCINS, CONDENSATION WITH A COMPOUND OF FORMULA HR (ALCOHOL, AMINE OR HYDRAZINE SUBSTITUTE) AND, OPTIONALLY ENDBOXYIN-3-CARBONYF-REDUCTION OF DAMS-3-FORMYLRIFAMYCIN THE CORRESPONDING FORMESV. AS AN ALTERNATIVE, 3- (CYANOCARBONYL) -RIFAMYCINS MAY BE CONVERTED TO THE V FORM BEFORE CONDENSATION WITH THE H-R COMPOUND. THESE DERIVATIVES MAY BE USED FOR THERAPEUTIC PURPOSES AND THEY CAN BE ADMINISTERED AS SUCH OR IN THE FORM OF SALTS, FOR THE TOPICAL OR GENERAL TREATMENT OF INFECTIOUS DISEASES SUCH AS PNEUMONIA, ABCES, FURUNCULOSIS, CYSTITIS, CHOLECYSTITIS, ETC. (CF DRAWING IN BOPI) RCN, OR (R ALIPHATIC GROUP CONTAINING 1-4C AND WHICH CAN PRESENT SUBSTITUTES CHOSEN FROM AMONG OH, |
priorityDate | 1977-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.